Arbutus Biopharma Corp (ABUS) — Net Asset Quality Index
Arbutus Biopharma Corp (ABUS) has a Net Asset Quality Index of 93.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $277.16 Million minus total liabilities of $16.99 Million yields net assets of $260.18 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Arbutus Biopharma Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Arbutus Biopharma Corp Net Asset Quality Index Over Time (1998–2025)
This chart shows how Arbutus Biopharma Corp's Net Asset Quality Index has evolved across 28 annual periods from 1998 to 2025. As of March 2026, the index stands at 93.9%, representing net assets of $260.18 Million against total assets of $277.16 Million USD. Explore ABUS cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Arbutus Biopharma Corp (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Arbutus Biopharma Corp from 1998 to 2025, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Arbutus Biopharma Corp.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.9% | $76.58 Million | $94.62 Million | $18.04 Million | ▲ +7.0 pp |
| 2024 | 73.9% | $97.37 Million | $131.71 Million | $34.34 Million | ▲ +0.5 pp |
| 2023 | 73.4% | $106.02 Million | $144.40 Million | $38.38 Million | ▲ +3.4 pp |
| 2022 | 70.0% | $136.85 Million | $195.42 Million | $58.57 Million | ▼ -12.8 pp |
| 2021 | 82.9% | $169.44 Million | $204.49 Million | $35.05 Million | ▲ +8.5 pp |
| 2020 | 74.4% | $101.97 Million | $137.08 Million | $35.11 Million | ▲ +5.5 pp |
| 2019 | 68.9% | $72.74 Million | $105.53 Million | $32.79 Million | ▼ -18.9 pp |
| 2018 | 87.9% | $200.23 Million | $227.91 Million | $27.67 Million | ▲ +10.9 pp |
| 2017 | 76.9% | $182.50 Million | $237.20 Million | $54.70 Million | ▲ +3.4 pp |
| 2016 | 73.6% | $203.00 Million | $275.90 Million | $72.90 Million | ▼ -3.3 pp |
| 2015 | 76.9% | $547.68 Million | $712.29 Million | $164.61 Million | ▲ +2.4 pp |
| 2014 | 74.5% | $88.00 Million | $118.20 Million | $30.20 Million | ▼ -8.1 pp |
| 2013 | 82.5% | $59.19 Million | $71.72 Million | $12.52 Million | ▲ +4.7 pp |
| 2012 | 77.8% | $40.92 Million | $52.60 Million | $11.68 Million | ▲ +39.8 pp |
| 2011 | 38.0% | $5.21 Million | $13.70 Million | $8.50 Million | ▼ -13.1 pp |
| 2010 | 51.1% | $10.73 Million | $21.02 Million | $10.29 Million | ▼ -33.4 pp |
| 2009 | 84.5% | $35.44 Million | $41.95 Million | $6.51 Million | ▼ -5.9 pp |
| 2008 | 90.4% | $38.29 Million | $42.34 Million | $4.05 Million | ▲ +16.5 pp |
| 2007 | 74.0% | $18.37 Million | $24.83 Million | $6.46 Million | ▲ +71.4 pp |
| 2006 | 2.6% | $155.53K | $6.03 Million | $5.88 Million | ▲ +102.6 pp |
| 2005 | -100.0% | $-18.49 Million | $18.50 Million | $36.99 Million | ▼ -74.5 pp |
| 2004 | -25.5% | $-10.50 Million | $41.10 Million | $51.60 Million | ▼ -111.1 pp |
| 2003 | 85.5% | $43.38 Million | $50.73 Million | $7.35 Million | ▲ +0.3 pp |
| 2002 | 85.2% | $45.35 Million | $53.22 Million | $7.87 Million | ▼ -5.7 pp |
| 2001 | 91.0% | $61.49 Million | $67.60 Million | $6.12 Million | ▼ -1.4 pp |
| 2000 | 92.3% | $30.03 Million | $32.52 Million | $2.49 Million | ▼ -1.0 pp |
| 1999 | 93.3% | $26.88 Million | $28.80 Million | $1.92 Million | ▲ +2.2 pp |
| 1998 | 91.1% | $14.43 Million | $15.83 Million | $1.40 Million | — |